Article info
Inflammatory bowel disease
Original article
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
- Correspondence to Professor Graham Lord, Department of Experimental Immunobiology, King's College London, 5th Floor, Tower Wing, Guy's Hospital, London SE1 9RT, UK; graham.lord{at}kcl.ac.uk
Citation
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
Publication history
- Received February 3, 2014
- Revised December 1, 2014
- Accepted December 23, 2014
- First published February 24, 2015.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Files in this Data Supplement:
- Data supplement 1 - Online supplement
- Data supplement 2 - Online figures
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/